customer service software
0

Global Ovarian Cancer Diagnostics and Therapeutics Market

  • Published Date: 18 Sep 2018
  • Number of Pages: 218
  • Category: Healthcare and Medical
  • Country: Global
An uncontrollable cell growth in the ovarian tissue causes ovarian cancer. It is one of the leading causes of death in women and hence is a growing concern across the globe. Hence, there is an increasing need to develop new medicines and therapies for its treatment along with the invention of new methods for the timely or early diagnosis of this cancer. Thus, the global market for ovarian cancer diagnostics and therapeutics shows immense potential for growth and development.

Market Dynamics

The global ovarian cancer diagnostics and therapeutics market accounted for more than USD 1100 million in 2015 and is expected to grow at a CAGR of around 10-16% during the forecast period. Following are the driving and restraining factors for this market:

Drivers:

--> Increasing incidences of ovarian cancer worldwide
--> Increasing population of aged women
--> Increase in healthcare expenditure
--> Increased government funding
--> Increasing healthcare awareness
--> Greater use of combination therapies for the treatment

Restraints:

--> Launch of generic drugs
--> Patent expiry of key drugs
--> Lack of accurate diagnosis of ovarian cancer

Market Segmentation

Segmentation on the basis of type:
--> Epithelial ovarian tumours
--> Ovarian germ cell tumours
--> Ovarian stromal tumours
--> Primary peritoneal carcinoma

Segmentation on the basis of cancer stage:
--> Stage I
--> Stage II
--> Stage III
--> Stage IV

Segmentation on the basis of diagnosis:

--> Physical examination
--> Biopsy
--> Blood tests
--> Human Chorionic Gonadotropin (HCG) test
--> Ultrasound
--> MRI
--> PET
--> CT Scans

Segmentation on the basis of treatment:
--> Chemotherapy
--> Targeted therapy
--> Immunotherapy
--> Hormonal therapy
--> Surgery

Segmentation on the basis of geography:
--> North America
--> Europe
--> Asia-Pacific
--> Middle East & Africa
--> South America

Opportunities

The global ovarian cancer diagnostics and therapeutics market is dominated by North America while Europe has the second largest market share. However, the Asia-Pacific region is anticipated to grow at comparatively higher rates during the forecast period owing to the increasing number of aging population and high prevalence of ovarian cancer. Countries such as China and India are expected to be the fastest growing markets for ovarian cancer diagnostics and therapeutics in the Asia-Pacific region.

Key Players

--> Bristol Myers Squibb Company
--> Eli Lilly and Company
--> GlaxoSmithKline Plc
--> Janssen Pharmaceuticals
--> Genentech Inc.
--> Astra Zeneca
--> Boehringer Ingelheim GmbH
--> Hoffmann La Roche Ltd.



Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada


> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America


> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe


> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe


> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific


> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa



This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage



Publisher Name : Market Litmus

The global market size of Nebulizer inhaler is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end

View Report

The global market size of Oxygen bag is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end

View Report

The global market size of Oxygen Regulator is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports